(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IPO4 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Ipo4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO4 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Ipo4 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IPO4 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Ipo4 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of IPO4 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Ipo4 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO Ipo4 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of IPO4 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO IPO4 (Homo sapiens) 6480464 Estradiol results in increased expression of IPO4 mRNA CTD PMID:23019147 and PMID:31614463 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of IPO4 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of IPO4 mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO IPO4 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ipo4 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ipo4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IPO4 mRNA CTD PMID:20702594 and PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ipo4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of IPO4 mRNA CTD PMID:17942748 and PMID:18796159 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Ipo4 (Mus musculus) 6480464 2 more ... CTD PMID:20702594 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of IPO4 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of IPO4 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO IPO4 (Homo sapiens) 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of IPO4 protein CTD PMID:32044396 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of IPO4 protein CTD PMID:34915118 4,4'-diaminodiphenylmethane decreases expression ISO Ipo4 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of IPO4 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO IPO4 (Homo sapiens) 6480464 bisphenol S results in increased expression of IPO4 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of IPO4 mRNA CTD PMID:21346803 acrylamide decreases expression ISO IPO4 (Homo sapiens) 6480464 Acrylamide results in decreased expression of IPO4 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO IPO4 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of IPO4 exon CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO IPO4 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of IPO4 promoter CTD PMID:30157460 aflatoxin M1 decreases expression ISO IPO4 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of IPO4 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO IPO4 (Homo sapiens) 6480464 Tretinoin results in decreased expression of IPO4 mRNA CTD PMID:23724009 and PMID:33167477 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of IPO4 mRNA CTD PMID:30779732 atrazine decreases expression ISO IPO4 (Homo sapiens) 6480464 Atrazine results in decreased expression of IPO4 mRNA CTD PMID:22378314 benzo[a]pyrene affects methylation ISO IPO4 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of IPO4 exon CTD PMID:30157460 benzo[e]pyrene decreases methylation ISO IPO4 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of IPO4 promoter CTD PMID:30157460 bisphenol A increases expression ISO IPO4 (Homo sapiens) 6480464 bisphenol A results in increased expression of IPO4 mRNA CTD PMID:17989879 bisphenol A multiple interactions ISO IPO4 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IPO4 gene CTD PMID:31601247 bisphenol A decreases methylation ISO IPO4 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of IPO4 gene CTD PMID:31601247 bisphenol A decreases expression ISO IPO4 (Homo sapiens) 6480464 bisphenol A results in decreased expression of IPO4 protein CTD PMID:37567409 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IPO4 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO IPO4 (Homo sapiens) 6480464 bisphenol A affects the expression of IPO4 mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IPO4 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of IPO4 mRNA CTD PMID:26496021 Bisphenol B increases expression ISO IPO4 (Homo sapiens) 6480464 bisphenol B results in increased expression of IPO4 protein CTD PMID:34186270 bisphenol F multiple interactions ISO IPO4 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of IPO4 gene CTD PMID:31601247 cannabidiol increases expression ISO Ipo4 (Mus musculus) 6480464 Cannabidiol results in increased expression of IPO4 mRNA CTD PMID:31052254 carbon nanotube increases expression ISO Ipo4 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO IPO4 (Homo sapiens) 6480464 IPO4 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 cisplatin decreases expression ISO IPO4 (Homo sapiens) 6480464 Cisplatin results in decreased expression of IPO4 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO IPO4 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of IPO4 mRNA CTD PMID:19320972 and PMID:19376846 cyclosporin A decreases expression ISO IPO4 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of IPO4 mRNA CTD PMID:22147139 cyclosporin A increases expression ISO IPO4 (Homo sapiens) 6480464 Cyclosporine results in increased expression of IPO4 mRNA CTD PMID:20106945 and PMID:25562108 decabromodiphenyl ether decreases expression ISO IPO4 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of IPO4 protein CTD PMID:31675489 dicrotophos increases expression ISO IPO4 (Homo sapiens) 6480464 dicrotophos results in increased expression of IPO4 mRNA CTD PMID:28302478 doxorubicin increases expression ISO IPO4 (Homo sapiens) 6480464 Doxorubicin results in increased expression of IPO4 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO IPO4 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of IPO4 protein CTD PMID:23301498 ethanol affects splicing ISO Ipo4 (Mus musculus) 6480464 Ethanol affects the splicing of IPO4 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO IPO4 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of IPO4 mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of IPO4 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of IPO4 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of IPO4 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Ipo4 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IPO4 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO IPO4 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of IPO4 mRNA CTD PMID:23649840 fulvestrant increases methylation ISO IPO4 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of IPO4 gene CTD PMID:31601247 fulvestrant multiple interactions ISO IPO4 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IPO4 gene and [bisphenol F co-treated with Fulvestrant] results in increased methylation of IPO4 gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of IPO4 gene CTD PMID:22079235 genistein increases expression ISO IPO4 (Homo sapiens) 6480464 Genistein results in increased expression of IPO4 mRNA CTD PMID:23019147 glafenine increases expression EXP 6480464 Glafenine results in increased expression of IPO4 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO IPO4 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of IPO4 mRNA CTD PMID:20044591 hydrogen peroxide decreases secretion ISO Ipo4 (Mus musculus) 6480464 Hydrogen Peroxide results in decreased secretion of IPO4 mRNA CTD PMID:21179422 ivermectin decreases expression ISO IPO4 (Homo sapiens) 6480464 Ivermectin results in decreased expression of IPO4 protein CTD PMID:32959892 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of IPO4 mRNA CTD PMID:28935588 methapyrilene decreases methylation ISO IPO4 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of IPO4 promoter CTD PMID:30157460 methyl methanesulfonate decreases expression ISO IPO4 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of IPO4 mRNA CTD PMID:23649840 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of IPO4 mRNA CTD PMID:24136188 nickel atom multiple interactions ISO Ipo4 (Mus musculus) 6480464 MT1 affects the reaction [Nickel affects the expression of IPO4 mRNA] and MT2 affects the reaction [Nickel affects the expression of IPO4 mRNA] CTD PMID:16166738 nickel atom increases expression ISO IPO4 (Homo sapiens) 6480464 Nickel results in increased expression of IPO4 mRNA CTD PMID:24768652 and PMID:25583101 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of IPO4 mRNA CTD PMID:24136188 ozone multiple interactions ISO Ipo4 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IPO4 mRNA CTD PMID:34911549 ozone multiple interactions ISO IPO4 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of IPO4 mRNA CTD PMID:35430440 paracetamol affects expression ISO Ipo4 (Mus musculus) 6480464 Acetaminophen affects the expression of IPO4 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IPO4 mRNA CTD PMID:33387578 paracetamol decreases expression ISO IPO4 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of IPO4 mRNA CTD PMID:21420995 and PMID:22230336 paracetamol increases expression ISO Ipo4 (Mus musculus) 6480464 Acetaminophen results in increased expression of IPO4 mRNA CTD PMID:19420014 paraquat increases expression EXP 6480464 Paraquat results in increased expression of IPO4 mRNA CTD PMID:32680482 pentachlorophenol increases expression ISO Ipo4 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of IPO4 mRNA CTD PMID:23892564 perfluorobutyric acid increases expression ISO Ipo4 (Mus musculus) 6480464 perfluorobutyric acid results in increased expression of IPO4 mRNA CTD PMID:34474067 perfluorononanoic acid increases expression ISO IPO4 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of IPO4 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO Ipo4 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO4 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of IPO4 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO IPO4 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of IPO4 protein CTD PMID:26879310 pirinixic acid multiple interactions ISO IPO4 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IPO4 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Ipo4 (Mus musculus) 6480464 pirinixic acid results in increased expression of IPO4 mRNA CTD PMID:23811191 progesterone decreases expression ISO IPO4 (Homo sapiens) 6480464 Progesterone results in decreased expression of IPO4 mRNA CTD PMID:18037150 propiconazole increases expression ISO Ipo4 (Mus musculus) 6480464 propiconazole results in increased expression of IPO4 mRNA CTD PMID:21278054 rotenone increases expression EXP 6480464 Rotenone results in increased expression of IPO4 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO IPO4 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IPO4 protein CTD PMID:37664457 silicon dioxide increases expression ISO IPO4 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of IPO4 mRNA CTD PMID:25895662 sodium arsenite affects methylation ISO IPO4 (Homo sapiens) 6480464 sodium arsenite affects the methylation of IPO4 gene CTD PMID:28589171 sunitinib increases expression ISO IPO4 (Homo sapiens) 6480464 Sunitinib results in increased expression of IPO4 mRNA CTD PMID:31533062 tamoxifen affects expression ISO Ipo4 (Mus musculus) 6480464 Tamoxifen affects the expression of IPO4 mRNA CTD PMID:17555576 temozolomide affects response to substance ISO IPO4 (Homo sapiens) 6480464 IPO4 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide increases expression ISO IPO4 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of IPO4 mRNA CTD PMID:15336504 testosterone increases expression ISO IPO4 (Homo sapiens) 6480464 Testosterone results in increased expression of IPO4 mRNA CTD PMID:33359661 tetrachloromethane increases expression ISO Ipo4 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of IPO4 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IPO4 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IPO4 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IPO4 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide decreases expression ISO IPO4 (Homo sapiens) 6480464 titanium dioxide results in decreased expression of IPO4 protein CTD PMID:30910687 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of IPO4 mRNA CTD PMID:24136188 valproic acid affects expression ISO Ipo4 (Mus musculus) 6480464 Valproic Acid affects the expression of IPO4 mRNA CTD PMID:17292431 valproic acid decreases expression ISO IPO4 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IPO4 mRNA and Valproic Acid results in decreased expression of IPO4 protein CTD PMID:19101580 and PMID:29501571 valproic acid increases expression ISO IPO4 (Homo sapiens) 6480464 Valproic Acid results in increased expression of IPO4 mRNA CTD PMID:23179753 valproic acid increases methylation ISO IPO4 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of IPO4 gene CTD PMID:29154799 valproic acid affects expression ISO IPO4 (Homo sapiens) 6480464 Valproic Acid affects the expression of IPO4 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of IPO4 mRNA CTD PMID:22570695